These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7236900)

  • 1. [Inhibitors of bone marrow stem cells proliferation. Possible applications during chemotherapy (author's transl)].
    Guigon M; Frindel E
    Bull Cancer; 1981; 68(2):150-3. PubMed ID: 7236900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further purification of a CFU-S inhibitor: in vivo effects after cytosine arabinoside treatment.
    Wdzieczak-Bakala J; Guigon M; Lenfant M; Frindel E
    Biomed Pharmacother; 1983; 37(9-10):467-71. PubMed ID: 6689548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of mice against lethal doses of 1 beta-D-arabinofuranosylcytosine by pluripotent stem cell inhibitors.
    Guigon M; Mary JY; Enouf J; Frindel E
    Cancer Res; 1982 Feb; 42(2):638-41. PubMed ID: 7055808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated granulocytes oxidize the endogenous stem cell inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK) to the stimulatory dimer: a redox-mediated mechanism for demand-induced hematopoietic regulation.
    Paukovits WR; Paukovits JB; Moser MH; Konstantinov S; Schulte-Hermann R
    Exp Hematol; 1998 Aug; 26(9):851-8. PubMed ID: 9694506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
    Wierenga PK; Konings AW
    Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of hematotoxic side effects of cytostatic drugs in mice by a synthetic hemoregulatory peptide.
    Paukovits WR; Guigon M; Binder KA; Hergl A; Laerum OD; Schulte-Hermann R
    Cancer Res; 1990 Jan; 50(2):328-32. PubMed ID: 2295072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CFU-S entry into cell cycle after irradiation and drug treatment.
    Guigon M; Frindel E
    Biomedicine; 1978 Jul; 29(5):176-8. PubMed ID: 719133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
    Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
    Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic precursor cell exhaustion is a cause of proliferative defect in primitive hematopoietic stem cells (PHSC) after chemotherapy.
    Gardner RV; Astle CM; Harrison DE
    Exp Hematol; 1997 Jun; 25(6):495-501. PubMed ID: 9197327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced proliferation of functionally competent bone marrow cells in different strains of mice treated with swainsonine.
    Oredipe OA; Furbert-Harris PM; Laniyan I; Green WR; White SL; Olden K; Parish-Gause D; Vaughn T; Griffin WM; Sridhar R
    Int Immunopharmacol; 2003 Mar; 3(3):445-55. PubMed ID: 12639822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro expansion of murine hematopoietic progenitor cells in liquid cultures for bone marrow transplantation: effects of stem cell factor.
    Han M; Kobayashi M; Imamura M; Hashino S; Kobayashi H; Maeda S; Iwasaki H; Fujii Y; Musashi M; Sakurada K
    Int J Hematol; 1993 Apr; 57(2):113-20. PubMed ID: 7684269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N; Chertkov J; Samoilina N; Zander A
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human placental low molecular weight factors inhibit the entry into cell cycle of murine pluripotent stem cells.
    Lopez M; Wdzieczak-Bakala J; Pradelles P; Frindel E
    Leukemia; 1991 Mar; 5(3):270-2. PubMed ID: 2013983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
    Jackson JD; Yan Y; Ewel C; Talmadge JE
    Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On control of the hematopoietic cell proliferation.
    Necas E; Sefc L; Znojil V
    Stem Cells; 1993 Jul; 11(4):319-25. PubMed ID: 8401255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of stem cell factor on the growth and radiation survival of tumor cells.
    Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
    Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of cyclophosphamide on the erythropoietic stem cell compartment].
    Milenković P
    Bilt Hematol Transfuz; 1980; 8(1):91-7. PubMed ID: 7337685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
    Down JD; Ploemacher RE
    Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AcSDKP, an inhibitor of CFU-S proliferation, is synthesized in mice under steady-state conditions and secreted by bone marrow in long-term culture.
    Wdzieczak-Bakala J; Fache MP; Lenfant M; Frindel E; Sainteny F
    Leukemia; 1990 Mar; 4(3):235-7. PubMed ID: 2314120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of the IL-6 transfected bone marrow stromal cells on the recovery of hematopoietic functions in bone marrow transplanted mice].
    Qin F; Xie S
    Zhonghua Xue Ye Xue Za Zhi; 1998 Nov; 19(11):583-6. PubMed ID: 11263343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.